Clinical Trial Update: Treatment of Hemorrhagic Fever With Ribavirin [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating ribavirin for the treatment of hemorrhagic fever, with the study currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhagic Fever

Drugs mentioned

• Ribavirin (ribavirin)

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Hemorrhagic Fever | Phase 2 | Status: ACTIVE_NOT_RECRUITING